Amendment requires the Director of the Office of National Drug Control Policy to request the Institute of Medicine of the National Academy of Sciences to conduct a study to examine certain aspects of iatrogenic addiction, which is associated with prescription drugs like OxyContin.

Purpose:

An amendment numbered 11 printed in House Report 109-387 to direct the ONDCP to request the Institute of Medicine of the National Academy of Sciences to enter into an agreement under which the Institute agrees to conduct a study on iatrogenic addiction associated with oxycodone hydrochloride controlled-release tablets and directs the ONDCP to report to Congress on the study.

House Amendment Code:

(A011)

House Tally Clerks use this code to manage amendment information.